Literature DB >> 27501999

Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.

Xue-Biao Wei1, Yuan-Hui Liu1, Peng-Cheng He1, Lei Jiang1, Ying-Ling Zhou1, Ji-Yan Chen1, Ning Tan1, Dan-Qing Yu2.   

Abstract

To investigate whether the addition of left ventricular ejection fraction (LVEF) to the TIMI risk score enhances the prediction of in-hospital and long-term death in ST segment elevation myocardial infarction (STEMI) patients. 673 patients with STEMI were divided into three groups based on TIMI risk score for STEMI: low-risk group (TIMI ≤3, n = 213), moderate-risk group (TIMI 4-6, n = 285), and high-risk group (TIMI ≥7, n = 175). The predictive value was evaluated using the receiver operating characteristic. Multivariate logistic regression was used to determine risk predictors. The rates of in-hospital death (0.5 vs 3.2 vs 10.3 %, p < 0.001) and major adverse cardiovascular events (14.6 vs 22.5 vs 40.6 %, p < 0.001) were significantly higher in high-risk group. Multivariate analysis showed that TIMI risk score (OR 1.24, 95 % CI 1.04-1.48, P = 0.015) and LVEF (OR 3.85, 95 % CI 1.58-10.43, P = 0.004) were independent predictors of in-hospital death. LVEF had good predictive value for in-hospital death (AUC: 0.838 vs 0.803, p = 0.571) or 1-year death (AUC: 0.743 vs 0.728, p = 0.775), which was similar to TIMI risk score. When compared with the TIMI risk score alone, the addition of LVEF was associated with significant improvements in predicting in-hospital (AUC: 0.854 vs 0.803, p = 0.033) or 1-year death (AUC: 0.763 vs 0.728, p = 0.016). The addition of LVEF to TIMI risk score enhanced net reclassification improvement (0.864 for in-hospital death, p < 0.001; 0.510 for 1-year death, p < 0.001). LVEF was associated with in-hospital and long-term mortality in STEMI patients and had additive prognostic value to TIMI risk score.

Entities:  

Keywords:  Left ventricular ejection fraction (LVEF); Mortality; ST segment elevation myocardial infarction (STEMI); Thrombolysis in myocardial infarction (TIMI)

Mesh:

Year:  2017        PMID: 27501999     DOI: 10.1007/s11239-016-1407-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  22 in total

1.  Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes.

Authors:  Xavier Bosch; Pierre Théroux
Journal:  Am Heart J       Date:  2005-08       Impact factor: 4.749

2.  The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.

Authors:  Vivian G Ng; Alexandra J Lansky; Stephanie Meller; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce Brodie; Ruchit Shah; Roxana Mehran; Gregg W Stone
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-10-03

Review 3.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  Catheter Cardiovasc Interv       Date:  2013-01-08       Impact factor: 2.692

4.  Evaluation of left ventricular ejection fraction in non-ST-segment elevation acute coronary syndromes and its relationship to treatment.

Authors:  Sean Jedrzkiewicz; Shaun G Goodman; Raymond T Yan; Francois R Grondin; Richard Gallo; Robert C Welsh; Kevin Lai; Thao Huynh; Andrew T Yan
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

5.  Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008.

Authors:  Liyew Desta; Tomas Jernberg; Ida Löfman; Claes Hofman-Bang; Inger Hagerman; Jonas Spaak; Hans Persson
Journal:  JACC Heart Fail       Date:  2015-03       Impact factor: 12.035

6.  Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Authors:  Peter Damman; Pier Woudstra; Wichert J Kuijt; Wouter J Kikkert; Tim P van de Hoef; Maik J Grundeken; Ralf E Harskamp; Jose P S Henriques; Jan J Piek; Jan G P Tijssen; Robbert J de Winter
Journal:  J Interv Cardiol       Date:  2012-09-12       Impact factor: 2.279

7.  Influence of left ventricular hypertrophy on infarct size and left ventricular ejection fraction in ST-elevation myocardial infarction.

Authors:  Łukasz A Małek; Mateusz Spiewak; Mariusz Kłopotowski; Joanna Petryka; Łukasz Mazurkiewicz; Mariusz Kruk; Cezary Kępka; Jolanta Miśko; Witold Rużyłło; Adam Witkowski
Journal:  Eur J Radiol       Date:  2011-02-15       Impact factor: 3.528

8.  Plasma angiopoietin-1 level, left ventricular ejection fraction, and multivessel disease predict development of 1-year major adverse cardiovascular events in patients with acute ST elevation myocardial infarction - a pilot study.

Authors:  Kuan-Liang Liu; Shu-Min Lin; Chih-Hsiang Chang; Yung-Chang Chen; Pao-Hsien Chu
Journal:  Int J Cardiol       Date:  2015-01-05       Impact factor: 4.164

9.  Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty.

Authors:  Giancarlo Marenzi; Marco Moltrasio; Emilio Assanelli; Gianfranco Lauri; Ivana Marana; Marco Grazi; Mara Rubino; Monica De Metrio; Fabrizio Veglia; Antonio L Bartorelli
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

10.  The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention.

Authors:  Pieter A van der Vleuten; Saman Rasoul; Willem Huurnink; Iwan Cc van der Horst; Riemer Hja Slart; Stoffer Reiffers; Rudi A Dierckx; René A Tio; Jan Paul Ottervanger; Menko-Jan De Boer; Felix Zijlstra
Journal:  BMC Cardiovasc Disord       Date:  2008-02-23       Impact factor: 2.298

View more
  3 in total

1.  Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention.

Authors:  Tuncay Kırıs; Eyüp Avcı; Aykan Çelik
Journal:  BMC Cardiovasc Disord       Date:  2018-03-02       Impact factor: 2.298

2.  The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.

Authors:  Song-Jian He; Jian-Xin Weng; Hai-Jun Chen; Hua-Qiu Li; Wen-Qin Guo; Qian Cao; Shuai Xu; Hong-Bing Yan; Chang-Nong Peng
Journal:  BMC Cardiovasc Disord       Date:  2021-01-28       Impact factor: 2.298

3.  A Nomogram for Predicting Hospital Mortality in Intensive Care Unit Patients with Acute Myocardial Infarction.

Authors:  Liao Tan; Qian Xu; Ruizheng Shi
Journal:  Int J Gen Med       Date:  2021-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.